Resmetirom, a selective liver thyroid hormone receptor (THR-) agonist, received approval from the FDA in 2024 for the treatment of adult patients with F2-F3 MASH (4)
Ozempic alternatives for weight loss While Ozempic is not approved as a weight loss medication, there are four GLP-1 medications that are approved specifically for chronic weight management: Wegovy pen (semaglutide), Wegovy pill (semaglutide), Saxenda (liraglutide) and Zepbound (tirzepatide)
One TikTok user summed up the appeal perfectly in a viral video with five million views
J Neurochem
Retatrutide already activates GLP-1, GIP, and glucagon receptors, making additional stacking unnecessary
Endocrine (2015) 48(1):10715.10.1007/s12020-014-0361-4 12 GilbertMPMarreMHolstJJGarberABaeresFMThomsenHet alComparison of the long-term effects of liraglutide and glimepiride monotherapy on bone mineral density in patients with type 2 diabetes